Suppr超能文献

用于治疗皮肤创伤的生物疗法:III 期和已上市疗法。

Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies.

机构信息

Stanford University School of Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Hagey Laboratory for Pediatric Regenerative Medicine , 257 Campus Drive West, Hagey Building GK106, Stanford, CA 94305 5148 , USA.

出版信息

Expert Opin Biol Ther. 2013 Nov;13(11):1523-41. doi: 10.1517/14712598.2013.842972. Epub 2013 Oct 5.

Abstract

INTRODUCTION

Normal wound healing mechanisms can be overwhelmed in the setting of complex acute and chronic tissue injury. Biological therapies are designed to augment and/or restore the body's natural wound healing abilities. There are a variety of available and emerging technologies utilizing this approach that have demonstrated the ability to augment wound healing.

AREAS COVERED

In this review, the clinical data on launched and emerging biological therapies for wound healing applications are summarized. The methodologies discussed include biological skin equivalents, growth factors/small molecules and stem cell-based therapies.

EXPERT OPINION

While many products possess convincing clinical data demonstrating their efficacy in comparison to standard treatment options, more robust, controlled studies are needed to determine the relative value among established and emerging biological therapies. Future bioengineering and stem cell-based approaches are of particular interest due to the simultaneous correction of multiple deficiencies present in the nonhealing wound.

摘要

简介

在复杂的急性和慢性组织损伤情况下,正常的伤口愈合机制可能会被打乱。生物疗法旨在增强和/或恢复人体的自然伤口愈合能力。目前有多种可利用的和新兴的技术采用这种方法,这些方法已经证明了增强伤口愈合的能力。

涵盖领域

在这篇综述中,总结了用于伤口愈合应用的已上市和新兴生物疗法的临床数据。讨论的方法包括生物皮肤等效物、生长因子/小分子和基于干细胞的疗法。

专家意见

虽然许多产品拥有令人信服的临床数据,证明与标准治疗方案相比,它们具有疗效,但仍需要更强大、更受控的研究来确定已建立和新兴生物疗法之间的相对价值。未来的生物工程和基于干细胞的方法特别令人感兴趣,因为它们可以同时纠正非愈合性伤口中存在的多种缺陷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验